Objective: Ultrasound-guided fine-needle aspiration (UG-FNA) is utilized to sample axillary lymph nodes in breast cancer patients. Diagnostic sensitivity is good but few data exist regarding the causes of false-negative results. Study Design: Fifty-four UG-FNAs of sentinel lymph nodes with histologic follow-up were identified. Gross and radiographic lymph node size, the percentage replaced by carcinoma and the cortical thickness were correlated with false-negative rates. Results: Thirty-seven aspirates were negative, 5 of these being false-negative (9%). True-positive lymph nodes averaged 1.3 cm in dimension while false-negatives averaged 0.92 cm. Percentage involvement by carcinoma for true-positive FNAs averaged 69% while false-negatives averaged 25%. Cortical thickness averaged 5.6 mm in true-positive FNAs but 2.9 mm in false-negatives. Conclusion: A relationship exists between lymph node size and the likelihood of a false-negative FNA. Lymph nodes <1.2 cm have a higher incidence of false-negative results. Lymph nodes with <30% involvement demonstrated a higher percentage of false-negatives than those with >30% replacement. Sentinel lymph nodes <1 cm appear to be relatively poor candidates for UG-FNA. Lymph nodes with a cortical thickness <3.5 mm are more often associated with a false-negative result than nodes with a thicker cortex.

Keywords:
Fine-needle aspiration, Axillary lymph nodes, Breast carcinoma, False-negative results, Node size
1.
Park SH, Kim MJ, Park BW, Moon HJ, Kwak JY, Kim EK: Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer. Ann Surg Oncol 2011;18:738-744.
2.
Popli MB, Sahoo M, Mehrotra N, Choudhury M, Kumar A, Pathania OP, Thomas S: Preoperative ultrasound-guided fine-needle aspiration cytology for axillary staging in breast carcinoma. Australas Radiol 2006;50:122-126.
3.
Alkuwari E, Auger M: Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer 2008;114:89-93.
4.
Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C, Turco P, Houssami N: Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat 2007;103:85-91.
5.
Jung J, Park H, Park J, Kim H: Accuracy of preoperative ultrasound and ultrasound-guided fine needle aspiration cytology for axillary staging in breast cancer. ANZ J Surg 2010;80:271-275.
6.
Chang MC, Crystal P, Colgan TJ: The evolving role of axillary lymph node fine-needle aspiration in the management of carcinoma of the breast. Cancer Cytopathol 2011;119:328-334.
7.
Fung AD, Collins JA, Campassi C, Ioffe OB, Staats PN: Performance characteristics of ultrasound-guided fine-needle aspiration of axillary lymph nodes for metastatic breast cancer employing rapid on-site evaluation of adequacy: analysis of 136 cases and review of the literature. Cancer Cytopathol 2014;122:282-291.
8.
O'Leary DP, O'Brien O, Relihan N, McCarthy J, Ryan M, Barry J, Kelly LM, Redmond HP: Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer. Br J Surg 2012;99:807-812.
9.
Solon JG, Power C, Al-Azawi D, Duke D, Hill AD: Ultrasound-guided core biopsy: an effective method of detecting axillary nodal metastases. J Am Coll Surg 2012;214:12-17.
10.
Rao R, Lilley L, Andrews V, Radford L, Ulissey M: Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol 2009;16:1170-1175.
11.
Gradishar WJ, et al: Breast cancer version 3.2014. J Natl Compr Cancer Netw 2014;12:542-590.
12.
Abe H, Schmidt RA, Sennett CA, Scimauchi A, Newstead GM: US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it. Radiographics 2007;27:(suppl 1):S91-S99.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.